RS BioTherapeutics Enters Into License Agreement With Synthonics for First Investigational Compound
https://www.yahoo.com/now/rs-biotherapeutics-enters-license-agreement-150000478.html
EXTENDED ABSORPTION OF LIOTHYRONINE FROM POLY-ZINC-LIOTHYRONINE (PZL) IN HUMANS
https://www.medrxiv.org/content/10.1101/2021.06.14.21258437v1.full.pdf
Phase 1 Clinical Trial of Poly-Zinc-Liothyronine Demonstrates Slow-Release Serum T3 Kinetics
https://www.liebertpub.com/doi/epub/10.1089/ct.2022%3B34.9-12